What question did this study set out to answer?

To explore the clinical course and mortality associated with pulmonary embolism, particularly in patients with underlying health conditions.

synapse

⌘+K

synapse

⌘+K

May 7, 1992

The Clinical Course of Pulmonary Embolism

Key Points

To explore the clinical course and mortality associated with pulmonary embolism, particularly in patients with underlying health conditions.
Analyzed data on patients diagnosed with pulmonary embolism.
Assessed mortality rates based on underlying diseases such as cancer and heart failure.
Compared recurrence rates of pulmonary embolism in different patient groups.
Clinically apparent pulmonary embolism is a rare cause of death when properly treated.
Most deaths are attributed to underlying diseases rather than the embolism itself.
Patients with cancer, heart failure, or chronic lung disease have a significantly higher one-year mortality risk.

Abstract

When properly diagnosed and treated, clinically apparent pulmonary embolism was an uncommon cause of death, and it recurred in only a small minority of patients. Most deaths were due to underlying diseases. Patients with pulmonary embolism who had cancer, congestive heart failure, or chronic lung disease had a higher risk of dying within one year than did other patients with pulmonary embolism.

Mark Helpful

Bookmark

Relay